BioScrip company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Merger | Merged

About BioScrip

BioScrip provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods.

BioScrip Headquarter Location

1600 Broadway Suite 700

Denver, Colorado, 80202,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest BioScrip News

Home Infusion Therapy Market Size [2022 - 2028] to reach USD 54.82 Billion [CAGR 6.8%] | Industry Share, Segments , Trends, Growth by Fortune Business Insights

May 23, 2022

North America to Dominate Market on Account of Rising Adoption of Innovative Technologies Handful of Vendors Covering Majority Shares Attributed to Massive Investment on Innovative Devices Drivers & Restraints- Rising Chronic Disease Prevalence to Amplify Market Growth In recent years, chronic diseases including cancer, congestive heart failure, chronic immune deficiencies, diabetes, and others have increased manifold. The World Health Organization (WHO) estimates that around 40% of the total country’s populace experiences chronic diseases, approximately 133 million. Hence, the increasing chronic disease prevalence is anticipated to bolster the global home infusion therapy market growth. Moreover, the expanding geriatric population is likely to complement the market’s growth. The growing hospital-acquired infections prevalence is boosting the market’s growth. The Center for Disease Control estimates approximately 1.7 million patients get infected with hospital-acquired infections annually. This boosts the demand for personalized intravenous drug infusion therapy, which is anticipated to be a vital factor driving the Home Infusion Therapy Market growth. Moreover, the rising consumer inclination towards home medical care is estimated to boost the market's growth significantly. However, the limited reimbursements for homecare may hamper the Home Infusion Therapy Market growth in the forthcoming years. Europe is anticipated to emerge as the second-largest region in this market on account of increasing investments in research & development activities by pharmaceutical companies in the region. The Botulinum Toxin Market in Asia Pacific, on the other hand, is expected to present lucrative opportunities owing to the rising disposable incomes in the region, which is creating demand for advanced cosmetic and therapeutic procedures and treatments. COVID-19 Impact- The global pandemic has devastated the global economic structure and stagnate the growth of numerous markets. The pandemic resulted in postponed or delayed elective procedures, which has negatively impacted the market's growth. However, the demand for home-based care has increased during the pandemic, boosting the demand for home infusion therapy. Furthermore, the telehealth sector has witnessed swift growth during the pandemic, positively stimulating the market’s growth. The Home Infusion Therapy Market Size is likely to expand astronomically in the forthcoming years. Click here to get the short-term and long-term impact of COVID-19 on this Market. For instance, in 2019, government authorities in England launched a campaign about botched cosmetic procedures and their impact on a person's physical and mental health. Moreover, several manufacturers are working on offering more advanced non-invasive cosmetic treatment products. Regional Insights- Presence of Key Players to Boost Growth in North America Significantly North America is predicted to attain the largest global home infusion therapy market share. Key players present in the region are likely to stimulate the market growth significantly. The swift adoption of home infusion therapy is likely to boost the growth of the market. Europe is projected to gain substantial growth due to the increasing burden of chronic diseases and the expanding geriatric population. Additionally, growing government initiatives are expected to fuel the growth of the Home Infusion Therapy Market. Asia Pacific is expected to experience significant growth in the global market. The growing consumer awareness regarding the therapy for the treatment of various chronic diseases is anticipated to amplify the regional market growth. Additionally, the increasing adoption of ingenious technologies is expected to augment market growth. The rest of the World is expected to gain considerable growth in the coming years. The growing inclination towards home-based medical care and the rising consumer awareness is anticipated to aid the market’s growth. Segmentation- On the basis of product, the Home Infusion Therapy Market Size is trifurcated into services, drugs, and devices. On the basis of indication, the market is fragmented into immunoglobulins, total parenteral nutrition, hydration therapy, chemotherapy, anti-infective, and others. Geographically, the market is classified into Asia Pacific, Europe, North America, and the Rest of the World. Quick Buy -  Home Infusion Therapy Market: It highlights the latest technological advancements and key trends of the market. It assimilates the challenges and restraints to growth and advises strategies to overcome those challenges. Competitive Landscape- Key Players Collaborate to Enhance their Market Reach The Home Infusion Therapy Market Size is fairly consolidated and comprises Baxter, Option Care Health Inc., Optum inc., and others as the top market players. They emphasize the development of innovative infusion pumps. They focus on the expansion of their geographical footprints domestically and internationally. To enhance their market reach, the key players adopt ingenious growth strategies such as new product launches, patents, technological developments, mergers, acquisitions, and others. For instance, Option Care Enterprise Inc. collaborated with BioScrip Inc. to establish a new firm, Option Care Health Inc., in August 2019. It became the largest independent, alternate site and home infusion service provider in the U.S. List of Key Players in the Global Home Infusion Therapy Market: Option Care Health Inc. (Illinois, U.S.) Optum, Inc. (Eden Prairie, U.S.) CareCentrix Inc. (Hartford, U.S.)

  • When was BioScrip founded?

    BioScrip was founded in 1993.

  • Where is BioScrip's headquarters?

    BioScrip's headquarters is located at 1600 Broadway, Denver.

  • What is BioScrip's latest funding round?

    BioScrip's latest funding round is Merger.

  • Who are the investors of BioScrip?

    Investors of BioScrip include Option Care.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.